Experts: Colon cancer deaths could make big drop

December 7, 2009 By MIKE STOBBE , AP Medical Writer

(AP) -- Colon cancer deaths could drop dramatically in the next decade because of better screening and treatment, according to an optimistic new prediction by top researchers.

The estimate was made in an annual report that shows that, overall, the U.S. death rate is continuing to decline, as it has since the 1990s.

The report released Monday focuses largely on cancers of the colon and rectum, which together are the third leading cancer killer in the United States. An estimated 50,000 people will die from it this year.

The battle against colorectal cancer has been a growing success story: The death rate dropped roughly 20 percent in the last 10 years, according to American Cancer Society figures.

The new report - by researchers at the advocacy group and other organizations - predicts that death rate will drop even more over the next decade. By 2020, the rate could be half what it was in 2000, they said.

The prediction assumes screening and improved chemotherapy treatment will become more and more common, and colon cancer contributors like smoking and red will decline.

The prediction is "optimistic but realistic," said Elizabeth Ward, who oversees surveillance and health policy at the American Cancer Society.

But some other experts said such a large drop could require far-reaching changes in how many people eat a healthier diet, have health insurance and can get good medical care.

"I think it's a little bit more optimistic than realistic," said Dr. Edward J. Benz Jr., president of the Dana-Farber Cancer Institute in Boston.

The new report looks at cancer trends from 1975 through 2006. The Cancer Society and others reported 2006 cancer death statistics in May, but this report provides further analysis and adds the predictions about colorectal cancer.

Cancer is the nation's No. 2 killer, behind heart disease, and accounts for nearly a quarter of annual deaths.

accounted for nearly 30 percent of cancer deaths in 2006. Cancers of the colon and rectum accounted for 10 percent, breast cancer in females about 7 percent and prostate cancers in men about 5 percent.

While deaths rates from many of the major cancers have been declining, the rate for liver cancer has been increasing. In women, deaths from pancreatic cancer are rising. In men, esophageal cancer and melanoma deaths are increasing.

There are differences among different racial and ethnic groups. Overall, cancer death rates are highest in black men and women. But pancreatic cancer death rates have been increasing for whites and not blacks.

But overall, cancer diagnoses and death rates have declined significantly, a success attributed largely to improvements in screening and treatment and declines in smoking.

The colorectal rate was about 17 deaths per 100,000 people in 2006. Better chemotherapy drugs have been used along with surgery to improve survival. And as of 2005, about half of U.S. adults aged 50 or older had had a recommended screening, such as a colonoscopy within the last 10 years or a stool blood test within the last year.

"It seems to me that it's a cascade of things that include medical science and technology advances," said Dr. Michael Fisch, head of general oncology at the University of Texas M. D. Anderson Cancer Center in Houston.

The report's prediction is based on a number of assumptions. Among other things, it assumes that the number of people who are screened will increase, fewer people will smoke or eat red meat more than twice a week, and the obesity rate will hold about steady.

Doctors say smoking and obesity contribute to colorectal cancer deaths, by increasing the odds of getting cancer or making treatment more difficult. While the U.S. adult smoking rate has gradually been declining for decades, the obesity rate has been climbing.

The new report was put together by the Cancer Society, the National Cancer Institute, the Centers for Disease Control and Prevention and the North American Association of Central Cancer Registries.

It's being published in the journal Cancer.

On the Net: Cancer report: http://www.interscience.wiley.com/cancer/report2009

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Related Stories

Recommended for you

Tracking how multiple myeloma evolves by sequencing DNA in the blood

December 10, 2017
Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the disease evolves over time will help to understand the disease and, ...

Landmark CAR-T cancer study published

December 10, 2017
Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

Study finds emojis promising tool for tracking cancer patients' quality of life

December 10, 2017
In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful in assessing patients' physical, emotional and overall quality ...

Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant

December 10, 2017
Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial ...

Blood test may help predict which breast cancers will recur

December 8, 2017
A blood test five years after breast cancer treatment helped identify some women who were more likely to relapse, long before a lump or other signs appeared, a preliminary study found.

Alcohol-abuse drug Antabuse kills cancer cells

December 8, 2017
A new study in Nature by an international team including researchers from Karolinska Institutet, reports that the alcohol-abuse drug Antabuse is effective against cancer. The study also identifies a potential mechanism of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.